Next Generation Genome Editing Market by Type of Gene Editing Technique -
Next Generation Genome Editing Market by Application Area -
Next Generation Genome Editing Market by Type of End User -
Next Generation Genome Editing Market by Region-
North America-
Europe-
Asia-Pacific-
Latin America-
Middle East & Africa-
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Next Generation Genome Editing Market Snapshot
Chapter 4. Global Next Generation Genome Editing Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter’s Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: By Type of Gene Editing Technique Estimates & Trend Analysis
5.1. By Type of Gene Editing Technique & Market Share, 2023 & 2031
5.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following By Type of Gene Editing Technique:
5.2.1. Recombinase-Based Editing
5.2.2. Prime Genome Editing
5.2.3. Bridge Editing
5.2.4. Base Editing
5.2.5. Retron Library Recombineering (RLR)
5.2.6. Transposon-Based Systems
5.2.7. Homology-Directed Repair (HDR)
5.2.8. Other emerging technologies
Chapter 6. Market Segmentation 2: By Application Area Estimates & Trend Analysis
6.1. By Application Area & Market Share, 2023 & 2031
6.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following By Application Area:
6.2.1. Drug Discovery and Development
6.2.2. Diagnostics
Chapter 7. Market Segmentation 3: By End User Estimates & Trend Analysis
7.1. By End User & Market Share, 2023 & 2031
7.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following By End User:
7.2.1. Biotechnology Companies
7.2.2. Academic Institutions
7.2.3. Government Laboratories
7.2.4. Contract Research Organizations
Chapter 8. Next Generation Genome Editing Market Segmentation 4: Regional Estimates & Trend Analysis
8.1. North America
8.1.1. North America Next Generation Genome Editing Market Revenue (US$ Million) Estimates and Forecasts by Type of Gene Editing Technique, 2024-2031
8.1.2. North America Next Generation Genome Editing Market Revenue (US$ Million) Estimates and Forecasts by Application Area, 2024-2031
8.1.3. North America Next Generation Genome Editing Market Revenue (US$ Million) Estimates and Forecasts by End User, 2024-2031
8.1.4. North America Next Generation Genome Editing Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
8.2. Europe
8.2.1. Europe Next Generation Genome Editing Market Revenue (US$ Million) Estimates and Forecasts by Type of Gene Editing Technique, 2024-2031
8.2.2. Europe Next Generation Genome Editing Market Revenue (US$ Million) Estimates and Forecasts by Application Area, 2024-2031
8.2.3. Europe Next Generation Genome Editing Market Revenue (US$ Million) Estimates and Forecasts by End User, 2024-2031
8.2.4. Europe Next Generation Genome Editing Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
8.3. Asia Pacific
8.3.1. Asia Pacific Next Generation Genome Editing Market Revenue (US$ Million) Estimates and Forecasts by Type of Gene Editing Technique, 2024-2031
8.3.2. Asia Pacific Next Generation Genome Editing Market Revenue (US$ Million) Estimates and Forecasts by Application Area, 2024-2031
8.3.3. Asia Pacific Next Generation Genome Editing Market Revenue (US$ Million) Estimates and Forecasts by End User, 2024-2031
8.3.4. Asia Pacific Next Generation Genome Editing Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
8.4. Latin America
8.4.1. Asia Pacific Next Generation Genome Editing Market Revenue (US$ Million) Estimates and Forecasts by Type of Gene Editing Technique, 2024-2031
8.4.2. Latin America Next Generation Genome Editing Market Revenue (US$ Million) Estimates and Forecasts by Application Area, 2024-2031
8.4.3. Latin America Next Generation Genome Editing Market Revenue (US$ Million) Estimates and Forecasts by End User, 2024-2031
8.4.4. Latin America Next Generation Genome Editing Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
8.5. Middle East & Africa
8.5.1. Middle East & Africa Next Generation Genome Editing Market Revenue (US$ Million) Estimates and Forecasts by Type of Gene Editing Technique, 2024-2031
8.5.2. Middle East & Africa Next Generation Genome Editing Market Revenue (US$ Million) Estimates and Forecasts by Application Area, 2024-2031
8.5.3. Middle East & Africa Next Generation Genome Editing Market Revenue (US$ Million) Estimates and Forecasts by End User, 2024-2031
8.5.4. Middle East & Africa Next Generation Genome Editing Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
Chapter 9. Competitive Landscape
9.1. Major Mergers and Acquisitions/Strategic Alliances
9.2. Company Profiles
9.2.1. Addgene
9.2.2. Beam Therapeutics
9.2.3. Bio Palette Co., Ltd
9.2.4. Caribou Biosciences
9.2.5. Cellectis
9.2.6. Creative Biogene
9.2.7. CRISPR Therapeutics.
9.2.8. Danaher Corporation
9.2.9. EdiGene, Inc.
9.2.10. Editas Medicine
9.2.11. ElevateBio
9.2.12. GenKOre
9.2.13. GenScript
9.2.14. Horizon Discovery Ltd.
9.2.15. Inscripta, Inc
9.2.16. Integrated DNA Technologies (IDT)
9.2.17. Intellia Therapeutics
9.2.18. KromaTiD, Inc
9.2.19. Maravai LifeSciences
9.2.20. Merck KGaA
9.2.21. Pairwise
9.2.22. Precision BioSciences
9.2.23. ProQR Therapeutics
9.2.24. QI-Biodesign
9.2.25. Recombinetics
9.2.26. Revvity
9.2.27. Sangamo Therapeutics, Inc.
9.2.28. Scribe Therapeutics
9.2.29. Shape TX
9.2.30. Synthego
9.2.31. Synthorx (part of Sanofi)
9.2.32. Other prominent players
This study employed a multi-step, mixed-method research approach that integrates:
This approach ensures a balanced and validated understanding of both macro- and micro-level market factors influencing the market.
Secondary research for this study involved the collection, review, and analysis of publicly available and paid data sources to build the initial fact base, understand historical market behaviour, identify data gaps, and refine the hypotheses for primary research.
Secondary data for the market study was gathered from multiple credible sources, including:
These sources were used to compile historical data, market volumes/prices, industry trends, technological developments, and competitive insights.
Primary research was conducted to validate secondary data, understand real-time market dynamics, capture price points and adoption trends, and verify the assumptions used in the market modelling.
Primary interviews for this study involved:
Interviews were conducted via:
Primary insights were incorporated into demand modelling, pricing analysis, technology evaluation, and market share estimation.
All collected data were processed and normalized to ensure consistency and comparability across regions and time frames.
The data validation process included:
This ensured that the dataset used for modelling was clean, robust, and reliable.
The bottom-up approach involved aggregating segment-level data, such as:
This method was primarily used when detailed micro-level market data were available.
The top-down approach used macro-level indicators:
This approach was used for segments where granular data were limited or inconsistent.
To ensure accuracy, a triangulated hybrid model was used. This included:
This multi-angle validation yielded the final market size.
Market forecasts were developed using a combination of time-series modelling, adoption curve analysis, and driver-based forecasting tools.
Given inherent uncertainties, three scenarios were constructed:
Sensitivity testing was conducted on key variables, including pricing, demand elasticity, and regional adoption.